Gilead Sciences shareholders re-elected nine directors and approved executive compensation plans at the 2026 annual meeting. The votes reflect shareholder confidence in the company's current leadership and governance.
Gilead Shareholders Approve Board, Executive Pay at Annual Meeting
GILDShareholder MeetingCorporate GovernanceExecutive CompensationBiotech

